The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

  • Medibank Private (MPL) has appointed David Koczkar as Chief Executive Officer, effective from 17 May
  • The role comes with a fixed remuneration of $1.5 million per year, plus a short-term incentive of up to 150 per cent of his annual salary
  • David Koczkar will be taking over the reins from Craig Drummond, who is retiring after five years in the role
  • Medibank Private is up 0.17 per cent, trading at $2.89

Medibank Private (MPL) has appointed David Koczkar as Chief Executive Officer, effective from 17 May.

The role comes with a fixed remuneration of $1.5 million per year, to be reviewed annually. He will also be eligible to receive a short-term incentive of up to 150 per cent of his annual fixed salary.

David Koczkar was appointed Group Executive and Chief Customer Officer of Medibank in September 2016. In this role, he was responsible for Medibank Group’s consumer businesses, including the health and diversified insurance portfolios, Live Better and the AHM business. Prior to this, he held the role of Chief Operating Office from March 2014.

“As our Chief Customer Officer David has been a champion for our customers and has played an instrumental role in the growth and re-positioning of Medibank,” said Medibank Chairman Mike Wilkins.

“This has enabled Medibank to implement some of the largest changes undertaken by the private health insurance sector in Australia. These changes have resulted in improved advocacy, retention and growth of customer numbers, significant improvement in the products and services experienced by our customers and enhanced performance for our shareholders.”

Before joining Medibank, Koczkar was the Group Chief Commercial Officer at Jetstar, where he was responsible for the airline’s customer and commercial businesses across the Asia Pacific region.

David Koczkar says it was an honour to be appointed to the role.

“For the last seven years, I have had the privilege of working to improve our relationship with our customers, their experience and enhancing the value that we provide them,” said Koczkar.

“I am thrilled to be able to continue this work, working with the amazing team at Medibank to continue to ensure our focus remains on meeting the needs of our customers and transforming the way we work as we become a broader healthcare company”.

David Koczkar will be taking over the reins from Craig Drummond, who is retiring after five years in the role. He will remain with the business until June 30 to assist with the handover.

Medibank Private is up 0.17 per cent, trading at $2.89 at 1:55 pm AEST.

MPL by the numbers
More From The Market Online

Firebrick Pharma’s US launch of Nasal Spray is nothing to be sneezed at

Australian pharmaceutical developer, Firebrick Pharma (ASX:FRE) has launched its latest product, Nasodine Nasal Spray, in the…

AVITA Medical drops revenue forecast for Q1

AVITA Medical (ASX:AVH) provided an update on its anticipated revenue for Q1 2024 - and has…

Little Green Pharma heading into Q2 cashed up after record sales

Little Green Pharma (ASX:LGP) wound up Q1CY24 with $5M in cash after posting record sales of…

Recce Pharmaceuticals up 6% on new antibiotic production milestone

Recce Pharmaceuticals (ASX:RCE) is trading up more than 6 per cent after producing a 5000-dose batch…